Nivolumab,Ipilimumab
BMS
['nivo', 'ipi/', 'melanoma']
current #aacramc chair is presenting in the poster session this morning, section 44 - board 6. come see her to learn about cell interaction networks in the response to ipi/nivo combo for metastatic melanoma, and ask her about #ecr initiatives at #aacr23 
Sr. Scientist in Translational Medicine @CytomXInc | @AACR Associate Member Council Past Chair. Views are my own 🇮🇹🇺🇸🏳️‍🌈